Elsevier, a global leader in research publishing and information analytics, has announced that the Cell Press port¬folio of journals will be expanding open access publishing options for authors from January 1, 2021.
Open access is an integral part of Elsevier's commitment to a more collaborative, inclusive and transparent world of research where authors, researchers, and academic institutions can share knowledge and build on each other's work to advance outcomes. Since authors around the world have diverse needs and preferences, Elsevier has been working collaboratively with the communities that Elsevier serves to test and learn from different ways of accelerating open access. As one of the fastest-growing open access publishers in the world, nearly all of Elsevier's 2,600 journals now enable open access publishing, including 500 fully open access journals.
From January 2021, all authors will have the option to publish open access across the entire range of the highly-regarded and influential Cell Press family of journals. The publishing route means all Cell Press authors can choose to make their research article available for everyone to read immediately following publication.
In enabling more open access, Elsevier seeks to offer substantial value to the scientific community relative to the quality and rigour of the editorial and publishing services it provides. As a result, for the titles that do not currently offer an open access publishing option, the article publishing charges (APCs) will be £7,000/€7,600/$8,900 for the majority of journals, and £7,800/€8,500/$9,900 for flagship title, Cell.
The journals will also continue to offer authors the option to publish through the subscription model. Since 2004, Elsevier has made all the subscription articles published in Cell Press research journals free for everyone to read from 12 months after publication in Open Archive.
The APCs will remain unchanged for most of existing gold open access journals, including the growing Cell Reports family, iScience and Heliyon. The Cell Press journals will offer open access publishing at APCs starting from £1,400/€1,500/$1,750.
As part of commitment to inclusion and diversity in science, Elsevier seeks to support researchers from low- and middle-income countries to participate and access research. Hence, Elsevier will waive open access APCs for all 69 Group A countries in the Research4Life program and reduce the APC by 50% for the remaining 57 Group B countries.
Alongside the expanded open access offering, Cell Press will continue to innovate in publishing to enhance scientific communication. Previous pioneering developments have included the Article of the Future concept, which introduced new article features including graphical abstracts and highlights, the STAR Methods format that enhances reproducibility in science and, recently the Community Review process designed to help authors find the right home for their paper quickly and easily through a unified, guided and consultative peer review process.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.Click here to read the original press release.